AGEN - Agenus Stock Trading

Agenus ( AGEN ) is a pharmaceutical company focused on immunotherapies. Its current lead candidates are balstilimab, which has the same target, PD-1, as Opdivo and Keytruda, and zalifrelimab, which has the same CTLA-4 target as Yervoy. Agenus can claim to have a larger cancer immunotherapy pip...

LEXINGTON, Mass. , May 14, 2020 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers and infections, announced today that it will present data on AGEN1181 at the American Society of Clin...

LEXINGTON, Mass. , May 13, 2020 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers and infectious diseases, announced today the FDA acceptance of the IND application for an alloge...